NDAINJECTIONINJECTABLE
Approved
Jun 1983
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3
Data completeness
3/8 — Basic
SOYACAL 20% (soybean oil) by HBM Alpha Therapeutics is patients, providing macronutrients (amino acids, dextrose and lipids) and micronutrients (electrolytes) parenterally. First approved in 1983.
Drug data last refreshed 1h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SOYACAL 20% is a soybean oil-based intravenous lipid emulsion that provides essential fatty acids, calories, and macronutrients to patients requiring parenteral nutrition. It delivers energy through beta-oxidation of fatty acids and serves as a substrate for membrane structure, bioactive molecule synthesis, and gene regulation. Indicated for patients unable to receive adequate nutrition orally or enterally.
LOE Approaching
As an aging product approaching loss of exclusivity with moderate competitive pressure (30), team size is likely stable or declining, with focus on cost management and market defense rather than expansion.
Mechanism of Action
patients, providing macronutrients (amino acids, dextrose and lipids) and micronutrients (electrolytes) parenterally. The amino acids provide the structural units that make up proteins and are used to synthesize proteins and other biomolecules or are oxidized to urea and carbon dioxide as a source…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (3)
Soybean Oil Trial of cArdiovascular Risk
Started Mar 2015
60 enrolled
Cardiovascular DiseaseDiabetesMetabolic Syndrome
Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in ICU Patients Requiring TPN
Started Nov 2008
100 enrolled
Parenteral Nutrition
Comparing Soybean Oil-Based (Intralipid) With an Olive Oil-Based (ClinOleic) Lipid Emulsion on Healthy Volunteers
Started Jun 2008
12 enrolled
Diseases, MetabolicInsulin Sensitivity
Worked on SOYACAL 20% at HBM Alpha Therapeutics? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.